On clinical trial fragility due to patients lost to follow up
Abstract Background Clinical trials routinely have patients lost to follow up. We propose a methodology to understand their possible effect on the results of statistical tests by altering the concept of the fragility index to treat the outcomes of observed patients as fixed but incorporate the poten...
Guardado en:
Autores principales: | Benjamin R. Baer, Stephen E. Fremes, Mario Gaudino, Mary Charlson, Martin T. Wells |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf76edffb4524432be3b3cc45054d90e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fragility Index as a Measure of Randomized Clinical Trial Quality in Adult Reconstruction: A Systematic Review
por: Carl L. Herndon, MD, et al.
Publicado: (2021) -
Fragility Index and Fragility Quotient in Randomized Controlled Trials on Corticosteroids in ARDS Due to COVID-19 and Non-COVID-19 Etiology
por: Maria Vargas, et al.
Publicado: (2021) -
Incidence and Predictors of Loss to Follow-Up Among Children Attending ART Clinics in Northeast Ethiopia: A Retrospective Cohort Study
por: Menshw T, et al.
Publicado: (2021) -
Melanoma: Staging and Follow-Up
por: Chryssoula Papageorgiou, et al.
Publicado: (2021) -
Time Until Loss to Follow-Up, Incidence, and Predictors Among Adults Taking ART at Public Hospitals in Southern Ethiopia
por: Dessu S, et al.
Publicado: (2021)